- Concept UI
- M000639744
- Scope Note
- Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS.
- Terms
-
Sodium-Glucose Transporter 2 Inhibitors
Preferred Term
Term UI
T000937586
Date12/11/2017
LexicalTag
NON
ThesaurusID
NLM (2019)
-
SGLT-2 Inhibitors
Term UI
T000937588
Date12/11/2017
LexicalTag
ABX
ThesaurusID
NLM (2019)
-
SGLT-2 Inhibitor
Term UI
T000996614
Date11/15/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Sodium-Glucose Transporter 2 Inhibitor
Term UI
T000996615
Date11/15/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
SGLT2 Inhibitor
Term UI
T000996239
Date11/14/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Gliflozins
Term UI
T000937606
Date12/12/2017
LexicalTag
NON
ThesaurusID
NLM (2019)
-
Gliflozin
Term UI
T000996616
Date11/15/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
SGLT2 Inhibitors
Term UI
T000937587
Date12/11/2017
LexicalTag
ABX
ThesaurusID
NLM (2019)